Henri-Alexandre Danlos

From WikiMD's WELLNESSPEDIA

File:DanloS 1519608.jpg
DanloS 1519608

Henri-Alexandre Danlos (1844–1912) was a French physician and dermatologist known for his contributions to the study of connective tissue disorders. He is best known for his work on the condition now known as Ehlers-Danlos syndrome, which he described in collaboration with Danish dermatologist Edvard Ehlers.

Early Life and Education[edit]

Henri-Alexandre Danlos was born in 1844 in Paris, France. He pursued his medical education at the University of Paris, where he developed an interest in dermatology and connective tissue disorders.

Career[edit]

Danlos worked at several prominent hospitals in Paris, including the Hôpital Saint-Louis, which was renowned for its dermatology department. He conducted extensive research on various skin conditions and connective tissue disorders, contributing significantly to the field of dermatology.

Ehlers-Danlos Syndrome[edit]

In 1908, Danlos, along with Edvard Ehlers, described a group of patients with hyperelastic skin, hypermobile joints, and a tendency to bruise easily. This condition was later named Ehlers-Danlos syndrome in their honor. The syndrome is now known to encompass a group of genetic disorders affecting the collagen synthesis, leading to defects in the connective tissues.

Legacy[edit]

Henri-Alexandre Danlos' work laid the foundation for further research into connective tissue disorders. His contributions have had a lasting impact on the field of dermatology and the understanding of genetic disorders affecting the connective tissues.

Related Pages[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.